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Abstract 
 
Parasitic nematodes cause serious diseases in animals, humans and plants. Chemoprophylaxis 
offers short-term benefits, but due to rapid development of drug resistance in parasites there is a 
pressing need for novel treatments of nematode infection. Parasitic nematodes secrete a 
structurally novel class of fatty acid and retinol binding (FAR) protein into the surrounding 
tissues of the host. These proteins are of interest because they may play an important role in 
scavenging fatty acids and retinoid from the host that are essential for the survival of the parasite 
and also because the localised depletion of such lipids may have immunomodulatory affects that 
compromise the host immune response. The genome of the free-living nematode Caenorhabditis 
elegans encodes eight FAR proteins (Ce-FAR-1 to 8) these fall into three discrete groups as 
indicated by phylogenetic sequence comparisons and intron positions, the proteins from parasitic 
nematodes falling into group A. 
 
The first goal of this project was to characterized Ce-FAR proteins by using bioinformatics tools. 
Second goal was to examine Ce-FAR-1 that includes the expression in competent Escherichia 
coli cells, purification by metal ion affinity chromatography, size exclusion chromatography, 
crystallization and crystals were cryo-protected with and without glycerol (v/v) for X-ray 
diffraction followed by bioinformatics based structure predication. Third goal was creation of 
point mutation in Ce-FAR-6 and Ce-FAR-7, expression analysis in competent E.coli cells and 
purification by metal ion affinity chromatography followed by lipid removal and dialysis for 
comparative ligand binding studies of Ce-FAR-6 mutant using fluorescence spectroscopy and 
Ce-FAR-7 mutant was phosphorylated in vitro with casein kinase II to measure with mass 
spectroscopy. 
 
 
Key words: FAR, Caenorhabditis elegans, metal ion affinity chromatography, size exclusion 
chromatography, crystallization, X-diffraction.  
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1. Introduction 
 
Nematodes are one of the most abundant groups of multicellular organisms on earth and parasitic 
forms directly cause more human disease and economic damage to domestic animals and crop 
plants than any other group of metazoan organisms, with the possible exception of insects 
(Garafalo et al., 2003). Approximately one sixth of the earth’s population, mostly in developing 
countries, suffers from nematode infections. Four of the fifteen tropical diseases, recorded by the 
world health organization (WHO) are caused by parasitic nematodes 
(www.who.int/neglected_diseases/diseases/en/).  
 
It was not until the mid 1980s, however, that nematode-specific retinoid-binding proteins with 
characteristics different from those of human tissues and plasma were finally identified (Sani et 
al., 1998). Evidence was built up that nematodes parasites require retinoid for three reasons. First, 
retinol plays an important role in gene activation, cell signalling, tissue differentiation and repair. 
Second, there is evidence that parasitic nematodes may require retinol variety of their metabolic 
and developmental processes, such as growth, differentiation, embryogenesis, glycoprotein 
biosynthesis and as antioxidants (Gudas et al., 1994). Third, retinol deficiency can alter the 
character of the host immune response and it is possible that such changes could be beneficial to 
the parasite (Nikawa et al., 1999). Parasitic worms are unable to synthesise the lipid de-novo and 
depend on import of essential lipids from their host, which makes the lipid binding proteins a 
good targets for new treatments (Kennedy et al., 1997). 
  
Two structurally novel families of lipid-binding proteins have been identified in parasitic 
nematodes. These are nematode polyprotein allergens/antigens (NPAs) with molecular weights 
of approximately 15 kDa and the fatty acid and retinol binding (FAR) proteins with molecular 
weights of approximately 20 kDa (Kennedy et al., 2000). The first FAR protein to be identified 
was the Ov-FAR-1 from the filarial agent Onchocerca volvulus, which cause river blindness in 
humans. A recombinant fragment of that protein was originally used as an immunodiagnostic 
tool to detect infection with O. volvulus (Bradley et al., 1991). Ten more FAR proteins from 
filarial species, all causing serious sickness in humans and animals have been studied. They 
share high sequence homology (79-100%) and belong to two major clusters i.e. nodule species 
such as Ov-FAR-1 and Bm-FAR-1 from Brugia malayi (causing elephantiasis) and some other 
lymphatic filarias (Garofalo et al., 2002). Since the characterisation of Ov-FAR-1, genes 
encoding similar proteins have been identified in a wide range of nematodes, including parasites 
of humans, animals, and plants (Prior et al., 2001).  
 
The secreted FAR proteins of parasitic nematodes may play a role in the pathogenesis of 
infection. The ocular and dermal disease manifestations of onchocerciasis, for example, are very 
similar to those associated with vitamin A deficiency and may reflect the localised depletion of 
this vitamin by Ov-FAR-1, produced and secreted by populations of O. volvulus concentrated in 
high numbers within the onchocercal nodules (Bradley et al., 2001). Retinol deficiency is 
immunosuppressive, and it is also possible it could alter the character of the host immune 
response to the advantage of the parasite. In addition to retinol, nematode FAR proteins are 
known to bind other lipid modulators of the host immune system such as arachidonic acid, and it 
may be relevant in this context that some species of tissue dwelling parasitic nematodes have 
been shown to adsorb and modify host lipids for secretion as biologically active eicosanoids (Liu 
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et al., 1992). Onchocercal nodules are rich in collagen and preliminary studies have indicated 
that Ov-FAR-1 may convey a retinoid messenger to tissues of the host which acts as a trigger to 
induce the formation of these collagenous structures (Nirmalan 1999). 
 
Genes encoding FAR proteins have now been described from many species of parasitic 
nematode (Tree et al., 1995, Blaxter, 1998, Prior et al., 2001), and inspection of expressed 
sequence tag and other surveys (see nema.cap. ed.ac.uk/Nest.html and Ref. 28) indicates that 
some or all parasitic nematodes may produce one or two types of FAR proteins 
(http://www.nematodes.net) (Garofalo et al., 2002). Recently it was identified that there are one 
NPA and six FAR genes in Haemonchus contortus and life stage gene expression of Hc-FAR-1 
to 6 revealed unique transcription patterns for each of these genes (Kuang et al., 2009). 
 
To understand the function of FAR proteins in parasitism, it is important to establish how many 
genes encoding FAR proteins exist in given specie, the function of the encoded proteins and one 
important in host-parasite interactions. At present functional characterisation of the FAR proteins 
has been impeded by the difficulties encountered in attempting to maintain and manipulate 
parasitic nematodes in a laboratory setting. None of the parasites can complete their life cycle 
outside the host. The free living nematode Caenorhabditis elegans is one of the most powerful 
model organisms in developmental biology (Gilleard, 2004). C. elegans has six chromosomes 
and 18,400 annotated genes currently available in wormbase data base 
(http://www.wormbase.org/, 2009). In the genome of the C. elegans, eight FAR proteins have 
been identified. They belong to three groups, (group A include Ce-FAR-1, 2, 6, group B include 
Ce-FAR-3, 4, 5 and group C include Ce-FAR-7, 8) (Garafalo et al., 2003).  The genes encoding 
the Ce-FAR proteins were found to be transcribed differentially through the life cycle of C. 
elegans, such that Ce-FAR-4 was weakly transcribed only at fourth larval stage, Ce-FAR-5 
weakly transcribed in all stages and Ce-FAR-1, Ce-FAR-2, Ce-FAR-3, Ce-FAR-6 and Ce-FAR-
7 predominated in males. 
 
The FAR proteins of parasitic nematodes seem to be secreted from the cell into the extra cellular 
environment, where they presumably play a role in the sequestration and transport of fatty acids 
and retinoid for the parasite (Garofalo et al., 2002). It is not known at this stage whether any of 
the C. elegans FAR proteins are secreted by the nematodes, and it is possible that the release of 
these proteins into the surrounding host tissue by parasites may reflect an adaptation of their 
function for parasitism.  In order to explore further possibilities for targeting FAR proteins for 
novel drug development, obtaining detailed structural information is essential but there are only 
two 3D structures of Lipid binding proteins from parasitic worms in protein data bank and both 
have FABP folds. There is a report of NMR structure of NPA protein (Meenan et al., 2005). 
Recently the first high resolution crystal structure of Ce-FAR-7 from C. elegans has been 
reported (Jordanova et al., 2009).  
 
In this study, we first characterized Ce-FAR proteins by using bioinformatics tools. Second goal 
was to express recombinant Ce-FAR-1 in E. coli cells, purified it by metal ion chromatography, 
size exclusion chromatography followed by crystallization, X-ray diffraction and bioinformatics 
based structure predication. Third goal was the creation of a point mutation in Ce-FAR-6 T50D 
and Ce-FAR-7 T26A, their expression and purification, followed by lipid removal and dialysis.  
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2 Materials and Methods 
 
2.1. Characterization of Ce-FAR Protein 
 
Ce-FAR genes were identified by tblastn and blastp searches of the C. elegans sequence data 
base available online at wormbase data base (http://www.wormbase.org/). High scoring matches 
were inspected to determine the relevance of the match, and a total of eight FAR genes (Ce-FAR-
1 to Ce-FAR8) were found (Appendix I) previously described by Garafalo et al., 2003. The 
SignalP program (SignalP 3.0 Server, 2009) was used to predict the presence and location of any 
signal peptide cleavage sites. The molecular weight and isoelectric point of the proteins were 
estimated using the ProtParam program (Expasy protparam server, 2009). Consensus sites for 
various post-translational modifications can be predicated in each of the Ce-FAR protein by 
using Expasy data base server (http://www.expasy.ch, 2009). The conserved amino acid 
sequences, hydrophilic & hydrophobic position, secondary structures, disulphide bridges and 
coil-coiled prediction of Ce-FAR-1 to Ce-FAR-8 were predicted using several algorithms 
programs run by geneDoc (http://motif.genome.jp/),  ClustalW2 (http://www.ebi.ac.uk/Tools/clu 
stalw2/index.html), JPRED server (http://www.compbio.dundee.ac.uk/Software/JPred/jpred.html, 
DSD Base (http://caps.ncbs.res.in/dsdbase//dsdbase.html) and Ch.EMBnet.org (http://www.ch.  
embnet.org/software/COILS_form.html). 
 
 
2.2. Ce-FAR-1 protein  
 
2.2.1. Large scale expression and Purification  
 
Ce-FAR-1 was cloned in pETM-11 LIC previously done by Fatima (Appendix II) and further 
transformed in E. coli BL21(DE3)pLysS competent cells. The few colonies from the LB agar 
plate were inoculated into LB
Kan&Chm
 and incubated over night at 37
0
C. The pre-culture was 
poured into 1lit LB
Kan&Chm
 and the optical density (OD600) were measured after every one hr until 
it reached 0.6-0.8. Isopropyl-beta-D-thio-galactopyranoside IPTG (1mM) was used to induce the 
cells for Ce-FAR-1 protein expression and the culture was grown overnight at 20
0
C. The cells 
were spun down at 5500 rpm for 25 min; the pellet was washed with 1X PBS buffer and frozen 
at -20
0
C for further use. 
 
The pellet of Ce-FAR-1was dissolved in binding buffer (20mM Tris base pH 8.5, 50mM NaCl, 
5mM β-mercaptoethanol and 20mM Imidazole) with one tablet per 50 ml of Complete Protease 
Inhibitor Cocktail, Roche, Germany. The cells were lysed by sonication. The high frequency 
(>20 kHz) of the sound waves cause the cells to burst open. Since heat is generated, samples 
must be kept on ice and the sonication was limited to short pulses (0.3 to 0.8 sec). After cell 
disruption the obtained lysate was centrifuged to remove the unwanted cell debris. The collected 
supernatant contained the solube protein fraction. Supernatant was filtered with 0.22µ filter 
paper for the removal of other cell debris. 
 
The supernatant was applied to a gravity-flow column (Bio-Rad) packed with Ni-NTA affinity 
resin (Qiagen, USA). The unbound bacterial proteins were removed from the column using 5-7 
column volume of binding or washing buffer (20mM Tris pH 8.5, 50mM NaCl, 5mM β-
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mercaptoethanol, 20mM Imidazole). The N-terminal His-tagged Ce-FAR-1 protein was eluted 
from the column using an elution buffer (20mM Tris pH 8.5, 50mM NaCl, 5mM β-
mercaptoethanol, 400mM Imidazole). The protein was further purified by gel filtration on a 
Superdex 75 HR 16/60 column (Pharmacia) pre-equilibrated with 20mM Tris pH 8.5, 50mM 
NaCl, 5mM β-mercaptoethanol. Ce-FAR-1 was concentrated using a Millipore concentration kit 
(Millipore, USA) for crystallization trials. The concentration of the protein was measured 
spectrophotometrically using the nanodrop method. The molar extinction coefficient (at 280 nm) 
for the proteins was estimated from their tyrosine and tryptophan content. The purified protein 
from affinity and gel filtration chromatography was analysed by SDS-PAGE according to the 
protocols and buffer recipe of Invitrogen, USA, 2009. After running, the gel was then stained 
with coomassie blue overnight on a rocking platform followed by de-staining and washing. 
 
 
2.2.2. Crystallization and X-ray diffraction 
 
Purified Ce-FAR-1 protein was sent to the high throughput crystallization facility at EMBL 
Hamburg for screening. The sparse matrix screens were set up using sitting drop vapour 
diffusion method in 96 well plates. It is a common method for initially determining potential 
crystallisation conditions. A wide selection of buffers, pH values, salts, additives and precipitants 
were screened. The plates were stored at 20°C and were automatically imaged for remote 
inspection. The best conditions were optimized manually with Grid screening also set up for 
hanging drop vapour diffusion, followed by streak and micro seeding. Crystals were grown on 
Easy Xtal tool 24 well plates (Qiagen, 2009) by equilibrating a mixture containing 1μL of 
protein and 1μL of a reservoir solution against 1ml of reservoir solution.  
 
X-ray diffraction analysis of single crystals with suitable dimensions was carried out on the X13 
beamline, EMBL at the synchrotron radiation facility DESY in Hamburg, Germany and ID29 
beamline at the European synchrotron radiation facility Grenoble, France. For X-ray diffraction 
experiments, crystals were transiently soaked in glycerol (v/v) corresponding to the reservoir 
solution but test supplemented with 10%, 15%, 20% and 25% (v/v) glycerol or the reservoir 
solution without glycerol as a cryo-protectant with the help a fine loop and mounted into a 
goniometer, which allow it to be positioned accurately within the X-ray beam and rotated.  
 
 
2.2.3. Bioinformatics based structure prediction 
 
The homology search against Ce-FAR-1 was performed by using NCBI blastp searches 
(www.ncbi.nlm.nih.gov, 2009) and domain organization was predicted using program run by 
motif search server (http://motif.genome.jp/). The secondary structure of Ce-FAR-1 and Ce-
FAR-7 was predicted using the consensus of several algorithms run by the JPRED server 
(http://www.compbio.dundee.ac.uk/Software/JPred/jpred.html) and a multiple sequence 
alignment was generated using the program ClustalW2 (http://www.ebi.ac.uk/Tools/ 
clustalw2/index.html).  
 
The X-ray structural model of Ce-FAR-7 were available at 1.79 Å resolution [PDB: 2w9y] and 
were used as a template to generate the 3D model of Ce-FAR-1. For this purpose, we choose 
input de novo protein modelling program ESyPred3D Web Server 1.0 (http://www.fundp.ac.be/ 
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sciences/Biologie/urbm/bioinfo/esypred/). The sequence of Ce-FAR-1 contains 166 amino acids, 
while Ce-FAR-7 contains 138 amino acids. High-resolution model for Ce-FAR-1 was 
constructed on the basis of their functional and secondary structural homology with Ce-FAR-7. 
The 3D structure of Ce-FAR-1 was validated with the PROCHECK (http://deposit.pdb.org/cgi-
bin/validate/adit-session-driver). The program generates ramachandran plot and accuracy.  The 
3D structure of Ce-FAR-1 was used to predict the amino acid residues in the active site domain 
by using Q-site Finder server (ligand binding site predication) (http://www. modelling. 
leeds.ac.uk/qsitefinder/)   
 
 
2.3. Ce-FAR-6 and Ce-FAR-7 proteins  
 
2.3.1. Mutagenesis, Sequencing and Test expression  
 
Ce-FAR-6 and Ce-FAR-7 were amplified from C.elegans cDNA and cloned into pETM-11 and 
pETM-11 LIC vectr previously done Rositsa (Appendix II). The specific primers were designed 
for the creation of point mutation in Ce-FAR-6 and Ce-FAR-7 by using the QuikChange
® 
Primer 
Design Program (Stratagene, 2009). The primers were designed to generate the desired mutations. 
The desired mutation was present in both of the mutagenic primers and it annealed to the 
opposite plasmid strand on the same sequence. Master Mix was prepared for PCR having all the 
reagents and its composition is given in QuikChange
® 
II
 
Primer kit (Stratagene 2009). The 
thermocycler was run according to the program given in QuikChange
® 
Primer kit. The amount of 
template used was 125ng, annealing temperature (TA), length of the primers along with melting 
temperature (Tm) and guanine and cytosine content are given in Table 1. 
 
Table1: Description of Ce-FAR-6 and Ce-FAR-7 primers for mutagenesis (Forward and 
Reverse).  
Assigned 
Name 
Forward Primer Reverse Primer TA TM Length GC % 
Ce-FAR-6 
T50E 
AAAGTTACTGAATACCTTA
AATCCATCGAGACTGAGG
AGAAAGCTGCTATTAAGG
AA 
TTCCTTAATAGCAGCTTTC
TCCTCAGTCTCGATGGAT
TTAAGGTATTCAGTAACTT
T 
60
 ο
 C 73
 ο
 C 
*FP 57  
*RP 57 
*FP  36.8 
*RP 36.8 
Ce-FAR-6 
T50D 
AGTTACTGAATACCTTAAA
TCCATCGATACTGAGGAG
AAAGCTGCTATTAAG 
CTTAATAGCAGCTTTCTC
CTCAGTATCGATGGATTT
AAGGTATTCAGTAACT 
60
 ο
 C 72
ο
 C 
*FP 52  
*RP 52 
*FP 36.5 
*RP 36.5 
Ce-FAR-7 
T26A 
CTCGAGTTCTCCTCATCA
ATTGCCGCTGACGAG 
CTCGTCAGCGGCAATTGA
TGAGGAGAACTCGAG 
60
 ο
 C 73
ο
 C 
*FP 33 
*RP 33 
*FP  54.5 
*RP 54.5 
* FP: Forward Primer, RP: Reverse Primer 
 
Forward and reverse primers for Ce-FAR-6 T50E, T50D and Ce-FAR-7 T26A were used for site 
directed mutagenesis by replacing the amino acid threonine (Thr) with asparatic acid (Asp), 
glutamic acid (Glu) and alanine (Ala) at position number 50 of Ce-FAR-6 and position number 
26 of Ce-FAR-7 respectively. The mutant non-methylated DNA was obtained by digestion of the 
methylated wild type DNA with endonuclease Dpn-1 by using the QuickChange®II Site-
Directed Mutagenesis Kit (Stratagene, 2009). The DpnI-treated plasmid DNA was then 
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transformed into E. coli (XL1-Blue) super competent cells, plated on LB
Kan
 plates over night at 
37
ο
C. Four colonies from Ce-FAR-6 T50D mutant plate, one from Ce-FAR-6 T50E mutant plate 
and six colonies from Ce-FAR-7 T26A mutant plate were transferred to a falcon tube with LB
Kan 
and incubated overnight at 37
ο
C. All the procedures were performed according to the 
QuickChange®II Site-Directed Mutagenesis Kit (Stratagene, 2009). 
 
Plasmid purification was done from the culture of bacteria harbouring pETM 11 and pETM-11 
LIC plasmid along with Ce-FAR-6 T50D and Ce-FAR-7 T26A mutant insert by using a 
Miniprep kit (Qiagen, Germany). The DNA concentration was measured using the nanodrop 
method. Ce-FAR-6 T50D and Ce-FAR-7 T26A clones were sequenced by Eurofins GmbH using 
T7 Fwd Primer. The obtained nucleotide sequence was then aligned with the wild type Ce-FAR-
6 and Ce-FAR-7 using the software Lalign (Expasy, 2009). 
 
The positive Ce-FAR-6 T50D and Ce-FAR-7 T26A clones were transformed in E. coli 
BL21(DE3)pLysS, BL21(DE3)RIL and BL21(DE3)RP competent cells on LB
Kan&Chm
 for test 
expression according to the protocols of Qiagen Bench Guide, USA, (2009). Colonies were 
inoculated into LB
Kan&Chm
 and incubated over night at 37
0
C followed by pre-culturing. Optical 
density (OD600) of the cultures was measured every half an hour until reaching 0.6-0.8. 1ml 
sample was taken before IPTG induction and 1ml sample after each time point (every half an 
hour) and the pellets were dissolved in SDS sample buffer (Novagen, 2009) and boiled. 1ml 
sample was taken at the end of expression and and the cells were lysed with Bug Buster lysis 
buffer (Novagen, 2009) and centrifuged. The supernatant was mixed with SDS sample buffer 
and boiled. The expression was analysed by SDS PAGE. 
 
2.3.2. Large scale expression and Purification  
 
Ce-FAR-6 T50D and Ce-FAR-7 T26A were expressed in BL21(DE3)RIL and BL21(DE3)pLysS 
E. coli competent cells respectively for large scale expression. Colonies were inoculated into 
LB
Kan&Chm
 and incubated over night at 37
0
C. The expression was performed as described in 
Expression and purification of Ce-FAR-1.  
 
Ce-FAR-6 T50D and Ce-FAR-7 T26A were purified by a nickel-column affinity and gel 
filtration chromatography according to the protocols described in Expression and purification of 
Ce-FAR-1. The purity of protein was analysis by SDS-PAGE according to the protocols and 
buffer recipe of Invitrogen, 2009. After running, the gel was then stained with Coomassie blue 
overnight followed by de-staining and washing. 
 
2.3.3. Lipidex incubation, Dialysis and Phosphorylation   
 
The purified Ce-FAR-6 T50D mutant protein was further treated with Lipidex-1000 (Perkin-
Elmer Life & Analytical Sciences, 2009) followed by dialysis for buffer exchange. The Lipidex 
was first washed with water and then equilibrated with 1X PBS. The matrix was mixed with the 
protein and incubated at 37
0
C for 1hr on a shaker for two serial incubations. The supernatant was 
filtered on a 22µ filter and put into the dialysis cassette (Thermo Scientific, 2009) for overnight 
dialysis against gel filtration buffer (Tris pH 8.5, 50mM NaCl, 5mM β-mercaptoethanol) at 40C 
for comparative ligand binding studies using fluorescence spectroscopy. 
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The purified Ce-FAR-7 T26A mutant protein was further dialyed for buffer exchange. The 
supernatant was filtered on a 22µ filter and put into the dialysis cassette (Thermo Scientific, 
2009) for overnight dialysis against gel filtration buffer (Tris pH 8.5, 50mM NaCl, 5mM β-
mercaptoethanol) at 4
0
C. The Ce-FAR-7 T26A mutant dialysed product was in-vitro 
phosphorylated with casein kinase II (NEB, 2009) using 500 U/ul CKII per 4 pg protein in the 
presence of 1mM ATP (NEB) and 1X CKII buffer (NEB) along with a non phosphorylated 
control mixed in water. The mixtures were incubated for 3 hr at 37
0
C.  
 
 
3 Results and Discussion   
 
Nematodes are probably the most abundant and ecologically diverse group of multicellular 
organism on Earth, and parasitic forms directly cause more human diseases and economic 
damage to domestic animals and crop plants than any other group of metazoan organisms, with 
the possible exception of insects. Lipid binding proteins released by nematode parasites have 
attracted increasing interest because of their potential role in nutrient acquisition, manipulation 
of the tissues they occupy, and countering host defence reactions (Kennedy, 2001).These 
proteins may interfere with intercellular lipid signalling to manipulate the defence reactions of 
the host or acquire essential lipids for the parasites. Nematodes produce two different types of 
small retinol and fatty acid binding proteins (14–20 kDa), neither of which have recognizable 
counterparts in other animal groups, including mammals. Both are helix-rich, in contrast to the 
beta rich small lipid transporters proteins of vertebrates such as the lipocalins, which are 
extracellular and secreted (Flower, 1996) and members of the FABP/P2/CRBP/ CRABP1 family 
(which are cytoplasmic lipid transporters, with exceptions only from nematodes) (Mei, 1997). 
One of these two families of helix rich lipid binding proteins of nematodes is synthesized as a 
large nematode polyproteins antigen (NPA) that is post-translationally cleaved into multiple 
copies of the functional protein of 14 kDa. The other family comprises the fatty acid and retinol 
binding proteins (FAR), which are the subjects of this report. 
 
Fatty acids and retinoids are poorly water soluble, oxidation-sensitive and therefore require 
specific carrier proteins to facilitate their intracellular and intercellular transport through aqueous 
environments (Flower, 1996). An early indication that parasitic nematodes may possess retinoid-
binding proteins that differ significantly from those of their host came from work with O. 
volvulus (Sturchler et al,. 1981). The retinol concentration within the onchocercal nodule was 
found to be eight times greater than that of the surrounding host tissue, suggesting that the 
parasite has the ability to sequester retinol from the carrier proteins of the host. It was not until 
the mid-80s, however, that nematode-specific retinoid-binding proteins with characteristics 
different from those of human tissues and plasma were finally identified (Sani et al,. 1985). 
 
Currently more than 40 FAR genes have been documented, although some of these are only 
represented by short read ESTs (Blaxter, 1998) (http://nema. cap.ed.ac.uk/Nest.html). The 
genome of the nematode C. elegans encodes eight FAR like proteins (Ce-FAR-1 to 8), that fall 
into three discrete groups as indicated by phylogenetic sequence comparisons as shown in Fig. 1 
(Garofalo et al., 2003). 
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Figure 1: Phylogenetic relationships between the FAR protein sequences of C. elegans.  
 
The FAR proteins of parasitic nematodes that have been used for functional studies cluster most 
closely together with the group comprising Ce-FAR-1, Ce-FAR-2 and Ce-FAR-6, and this group 
of Ce-FAR proteins may therefore most closely resemble the ancestral homologue from which 
the parasite proteins evolved (Garofalo et al., 2003). The basic aims of this study are already 
mentioned, the focus was the bioinformatics characterization of Ce-FAR proteins, mutagenesis 
and sequence analysis of Ce-FAR-6 T50D and Ce-FAR-7 T26A, expression analysis of Ce-
FAR-1, Ce-FAR-6 T50D and Ce-FAR-7 T26A in E.coli, protein purification by affinity and size 
exclusion chromatography and crystallization. 
 
 
3.1. Characterization of Ce-FAR protein 
 
3.1.1. Classification 
 
Eight far genes of C. elegans including assigned name, gene ID, groups, chromosomal 
localization and size (wormbase data base, 2008) are presented in Table 2 as initally described by 
Garofalo et al., 2003.  
 
Table 2: far genes are classified on the basis of assigned name, gene ID, group, chromosomal 
location and size. 
Assigned 
Name  
Gene ID 
Groups 
Chromosomal 
Localization 
Size 
(Nucleotide) 
Size                
(Amino acid) 
Ce-FAR-1 WB00001385 A III 549 182 
Ce-FAR-2 WB00001386 A III 549 182 
Ce-FAR-3 WB00001387 B V 570 189 
Ce-FAR-4 WB00001388 B V 618 205 
Ce-FAR-5 WB00001389 B V 531 176 
Ce-FAR-6 WB00001390 A IV 555 184 
Ce-FAR-7 WB00001391 C II 417 138 
Ce-FAR-8 WB00001392 C III 699 232 
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Eight Ce-FAR proteins according to their molecular weight, iso-electric point and extinction 
coefficient (Expasy protparam tool, 2009) has been shown in Table 3 as initally described by 
Garofalo et al., 2003.  
 
Table 3: Ce-FAR proteins are characterized on the basis of molecular weight, iso-electric point 
and extinction coefficient. 
Assigned Name  Molecular  weight Iso-electric point 0.1%Extinction coefficient 
Ce-FAR-1 20KDa 6.98 0.445 
Ce-FAR-2 20KDa 5.73 0.521 
Ce-FAR-3 20KDa 8.76 0.356 
Ce-FAR-4 23KDa 10.09 0.322 
Ce-FAR-5 19KDa 5.17 0.377 
Ce-FAR-6 20KDa 8.63 0.434 
Ce-FAR-7 15KDa 6.20 0.113 
Ce-FAR-8 26KDa 5.26 0.952 
 
All Ce-FAR proteins, with the exception of Ce-FAR-7, possess a hydrophobic secretory signal 
peptide, and the proteins are thus predicted to be secreted from the cell into the extracellular 
environment, where they presumably play a role in the sequestration and transport of fatty acids 
and retinoids. The signal sequence of Ce-FAR proteins was obtained in the sequenced fragment 
using SignalP 3.0 Server (2009) shown in Fig. 2 in italic and underscored red (Garofalo et al., 
2003). Immunolocalisation studies have shown that the FAR proteins of filarial nematodes are 
released by the parasites into the extracellular environment (Tree et al., 1995) and similar results 
have also been reported for the plant parasite G. pallida (Prior et al., 2001). It is not known at 
this stage whether any of the Ce-FAR proteins are infact secreted by the nematode. Recently it 
has been shown that Ce-FAR-7, which does not have a signal peptide, is not secreted in to the 
extracellular environment (Jordanova, et al., 2009).  
 
 
3.1.2. Posttranslational Modifications of Ce-FAR protein 
 
Consensus sites for various post-translational modifications can be identified in each of the FAR 
proteins, but most of these are short, commonly occurring sequences. With the exception of N-
linked glycosylation (Prior et al., 2001), no evidence has yet been provided that any of them are 
utilised in vivo. All the FAR proteins of parasitic nematodes have putative N-linked 
glycosylation sites, but the number and location of the sites is not always conserved (Garofalo et 
al., 2002) and the FAR proteins of some parasite species do not appear to be glycosylated (Tree 
et al., 1995, Garofalo et al., 2002). It is interesting that only those filarial parasites with 
unsheathed microfilarae produce glycosylated proteins. It is possible that the FAR proteins play 
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an important role in parasitism and the absence of glycosylation is essential to enable their 
secretion through the microfilarial sheath into the surrounding host tissue, but the true biological 
significance of the difference in glycosylation between filarial parasites with sheathed and 
unsheathed microfilarae remains to be established (Garofalo et al., 2002). Three of the Ce-FAR 
proteins (Ce-FAR-4, Ce-FAR-6, Ce-FAR-8) that have putative N-linked glycosylation sites are 
underscored in Fig. 2 (NetNGlyc 1.0 server, 2009) but in Ce-FAR4, the glycosylation site is 
coincident with the putative casein kinase II phosphorylation site and it may not therefore be 
utilised. N-linked glycosylation sites were not observed in other Ce-FAR proteins (Garofalo et 
al., 2003).  
 
The putative casein kinase II phosphorylation site of Ce-FAR-1 to Ce-FAR-8 that is highlighted 
boldface type with blue mark in Fig. 2 (NetPhos 2.0 Server, 2009), however, is conserved in all 
the nematode FAR proteins that have been characterised to date, and it may therefore be of 
importance (Garofalo et al., 2003). Phosphorylation is known to have a significant affect on the 
biological activity of many proteins, including those involved in gene regulation (Ventura et al., 
2001) and it can control homodimerisation (Surette et al,. 1996) and even the stability of alpha-
helices (Szilak et al,. 1997).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Multiple sequence alignment of Ce-FAR protein. The putative hydrophobic signal peptides that 
were predicated by the signalP program are shown in italic/lowercase letters and underscored. 
Consensus N-linked glycosylation site are underscored, and conserved casein kinase II phosphorylation 
site is in boldface type.  
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3.1.3. Secondary structure of Ce-FAR Protein 
 
FAR proteins are identical and secondary structure prediction programmes indicate that Bm-
FAR-1 has the same helix-rich structure as Ov-FAR-1 (Garofalo et al., 2002). Multiple sequence 
alignment of Ce-FAR proteins, hydrophilic and hydrophobic positions of amino acids and 
secondary structure predictions indicate that the proteins are rich in alpha helix, with no 
significant content of beta extended structure as shown in Fig. 3 (Garofalo et al., 2003). Circular 
dichroism data agree with the predictions, as shown for Ov-FAR-1 (Kennedy et al., 1997), Ce-
FAR-1 to 6 (Garofalo et al., 2003) and Ce-FAR-7 (Kostova et al., 2009, unpublished). The high 
helical content of the FAR family was confirmed by the crystal structure of Ce-FAR-7 (PDB ID 
2w9y), showing nine helices and no beta structures in the protein (Jordanova et al., 2009). The 
predominance of helical structure thus appears to be a universal characteristic of the parasitic 
proteins and C. elegans FAR do not seem to differ significantly in this respect from those of the 
parasites. It is a factor that clearly sets them apart from the similar sized lipid-binding proteins of 
vertebrates, such as the lipocalins and members of the cytoplasmic lipid transporters family of 
proteins, which are all beta rich (Noy, 2000, Cowan et al., 1993). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Ce-FAR protein relationships. A multiple sequence alignment and secondary structural 
prediction for the C. elegans FAR proteins. In the consensus line, uppercase letters refer to those amino 
acids that are conserved at that position in all of the sequences, and lowercase letters refer to amino 
acids that are conserved at that position in more than half of the sequences. The Jnet line shows the 
secondary structure prediction from submission of the multiple alignments to the Jpred secondary 
structure prediction program. H represents a prediction for alpha helix, and the gaps indicate regions for 
which no structural prediction emerged. No beta structure was predicted by Jpred or any other secondary 
structure prediction programs. The bottom line indicates conserved hydrophobic (O) and hydrophilic (+) 
positions. 
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A characteristic feature of Ce-FAR-7 and Ce-FAR-8 is the possession of four (including signal 
peptides) cysteines, respectively, in the predicted mature proteins. The other Ce-FAR proteins 
possess no cysteines, except Ce-FAR-3, which has one in the putative leader/signal peptide 
(position 11). The cysteine positions in Ce-FAR-7 (9, 41, 46, 97) and Ce-FAR-8 (6, 132, 152, 
208) are dissimilar, and the fourth cysteine in Ce-FAR-8 may be lost if the C-terminal extension 
of this protein is trimmed post-translationally (Fig. 4). Given the weighting typically attributed to 
the occurrence and position of cysteines in protein families, it is arguable that Ce-FAR-7 and Ce-
FAR-8 are not typical of the FAR family. They may however represent specialized or ancestral 
forms of FAR proteins with distinctive functions (Garofalo et al., 2003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Multiple sequence alignment of Ce-FAR protein (Ce-FAR3, Ce-FAR-7 and Ce-FAR8). Figure 
shows Cysteines residue in Ce-FAR3, Ce-FAR-7 and Ce-FAR8 highlighted in Bold/red mark.    
 
The most notable structural feature associated with parasite FAR proteins is the strong prediction 
for coiled-coil structures (Prior et al., 2001, Garofalo et al., 2002, Kennedy et al., 1995). There 
was a strong prediction for the occurrence of coiled-coils in Ce-FAR-1, Ce-FAR-2 and Ce-FAR-
3, but not for the others. The significance of these observations is unclear. Coiled-coil 
interactions can impart significant stability to proteins and such interactions could underlie the 
finding that FAR proteins are extremely thermostable (Kennedy et al., 1997). Where two 
stretches of predicted coiled-coil occur within a single protein, coiled-coil interactions could 
either act between the two regions/domains of the same protein molecule or be involved in 
intermolecular associations and perhaps even be responsible for specific recognition between 
molecules (Burkhard et al., 2001). 
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3.2. Ce-FAR-1 protein 
 
3.2.1. Expression and Purification  
 
The Ce-FAR-1 (His-tag) construct was transformed into BL21(DE3)pLysS cells and expression 
was induced by IPTG. Growth was monitored every one hour until OD600 was between 0.6-0.8 
(Fig. 5). The constructs were successfully expressed and the pellets were stored for futher 
purification of the desired protein.  
 
 
 
 
 
 
 
Figure 5: Growth curve of BL21(DE3)pLysS. The plot shows the OD value against time of Ce-FAR-1 (h). 
 
A two steps purification of the Ce-FAR-1 protein was carried out by affinity chromatography by 
using a nickel column followed by gel filtration. Cell lysates from E. coli BL21(DE3)pLysS 
containing recombinant Ce-FAR-1 were applied to a Ni column. Ce-FAR-1 protein was eluted 
and concentrated. It was applied to a Superdex 75 column for gel filtration. The protein peak was 
detected by A280 absorbance with an Äkta Purifier system (HPLC) as described by Jinsong et al., 
2009. The fraction eluted from Superdex 75 columns contained pure protein and it was 
concentrated for further crystallization experiments. The final yield of pure Ce-FAR-1 from 2 L 
culture is given in Table 4.  
 
Table 4: Protein yield during two step purification of Ce-FAR-1. 
 
The purification was repeated six times and the purity of protein collected for crystallization was 
analysed by SDSPAGE as shown in Fig 6.  
Purification Steps 
Protein     
(mg/ml) 
Protein     
(mg/ml) 
Protein     
(mg/ml) 
Protein     
(mg/ml) 
Protein     
(mg/ml) 
Protein     
(mg/ml) 
Ni-affinity column 4.5 mg/ml 4 mg/ml 3 mg/ml 4.6 mg/ml 5.5 mg/ml 2.5 mg/ml 
Superdex 75 column 8.5 mg/ml 8.9mg/ml 6 mg/ml 5.5 mg/ml 5 mg/ml 6 mg/ml 
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Figure 6: (A, B, C, C, D, E and F) the peaks show the profile of gel filtration chromatography of Ce-FAR-1 
protein. The volume in ml is plotted on X axis and on Y axis is the absorbance at 280nm. An SDS-PAGE 
image shows the profile of affinity and gel filtration chromatography of Ce-FAR-1 protein. The size of the 
product was 21KDa compared with marker (M) and FT is the Flow through from affinity chromatography. 
In SDS-PAGE image, affinity chromatography (Ni) shows 21KDa band along with the bands of gel 
filtration chromatography (GF) fraction taken from micro well plates.   
 
 
3.2.2. Crystallization and X-ray diffraction 
 
Purified protein Ce-FAR-1 after gel filtration was further used in the crystallization experiment 
with concentrations between 6-9 mg/ml. Five conditions {(i) 10% PEG4000, Hepes pH 7.5, 20% 
Isopropenol (ii) 10% PEG8000, Hepes pH 8 (iii) 8% PEG8000, Tris pH 8.5  (iv) 10% PEG6000, 
MES pH 6.0 (v) 10% PEG6000, Hepes pH 7.0} gave promising crystals from the sparse matrix 
screens set up at the high throughput crystallization facility at EMBL Hamburg (Fig. 7A). 
Further the condition 13% PEG6000 as precipitant with 0.1M MES buffer pH 6.4 was selected 
for screening with an additive screen (Hampton Research). Three additives were chosen after 
getting the results for crystal optimization as shown in Fig.7B - 0.1M Adenosine-5-triphosphate 
disodium salt hydrate, 40% v/v Pentaerythritol ethoxylate (3/4 EO/OH), 50% v/v Jeffamine M-
600 pH 7.0  (Hampton research additive screening, 2009). 
 
 
 
 
 
 
 
 
 
 
 
Figure 7 (A) HTC Hamburg screening for crystallization of Ce-FAR-1 protein. All five conditions show 
small crystal formation of Ce-FAR-1 having 10% PEG4000, Hepes pH 7.5, 20% Isopropenol, 10% 
PEG8000, Hepes pH 8,  8% PEG8000, Tris pH 8.5, 10% PEG6000, MES pH 6.0, 10% PEG6000, Hepes 
pH 7.0. (B) Images from HTC Hamburg additive screening show three best conditions having 13% 
PEG6000 in 0.1M MES pH 6.4, along with 0.1M Adenosine-5-triphosphate disodium salt hydrate and 
12%, 14% and 15% PEG6000 in 0.1M MES pH 6.6, 40% v/v Pentaerythritol ethoxylate (3/4 EO/OH). 
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Several grid optimization screens were set up with Polyethylene glycol 6000 (PEG6000) as a 
precipitant in the concentration of 10 % to 15% and 0.1M MES buffer at pH 6.0 to 6.8.  After 
few days, small rectangular shape crystals appeared (Fig. 8B). In order to obtain bigger crystals 
and check diffraction, initial conditions were further optimized by seeding techniques or 
crystallization with additives. Streak seeding was performed as well, the idea behind is to 
differentiate the process of crystal growth from nucleation and obtain bigger crystals. In general, 
the degree of super saturation required for nucleation is higher than that required for crystal 
growth. When crystal seeds are added (take a small drop from best crystal from other screening), 
the equilibrium can shift towards crystal formation, and avoids the random nature of spontaneous 
nucleation. The growth was satisfactory having single crystals as shown in Fig. 8D.  Finally, 
successful micro seeding and co-crystallization with additives were achieved. The additives, that 
gave the best results were 0.1M Adenosine-5-triphosphate disodium salt hydrate, 40% v/v 
Pentaerythritol ethoxylate (3/4 EO/OH) and 50% v/v Jeffamine M-600 pH 7.0 from Hampton 
Additive screen (Fig. 7B). Larger rectangular shape crystals were obtained (Fig. 8E, F & G).  
Figure 8: Ce-FAR-1 crystals at different conditions (A) the image shows very small crystal formation of 
Ce-FAR-1 with 12% PEG6000 and 0.1M MES 6.5. (B) The Image shows small rectangular shape crystals 
of Ce-FAR-1 with 13% PEG6000 and 0.1M MES pH 6.6. (C) The image shows small streak seeded 
crystals of Ce-FAR-1 into 12% PEG6000 and 0.1M MES pH 6.6 or (D) 14% PEG6000 and 0.1M MES pH 
6.5. (E) The image shows large micro seeded crystals of Ce-FAR-1 into 14% PEG6000 and 0.1M MES 
pH 6.6 or (F) 11% PEG6000 and 0.1M MES pH 6.4 or 0.1M Mes pH 6.2 (G) The Image shows the 
crystals of Ce-FAR-1 with  10% PEG6000 and 0.1M MES pH 6.3and  0.1M Adenosine-5-triphosphate 
disodium salt hydrate as an additive and 12% and 15% PEG6000 in 0.1M MES pH 6.6, 40% v/v 
Pentaerythritol ethoxylate (3/4 EO/OH) as an additive.  
 
Single crystals of above conditions with suitable dimension were selected for X-ray diffraction 
tests. Crystals were either mounted directly from the well solution, since it contained high 
percentage of PEG or where necessary cryo-protected with 10% to 25% glycerol (v/v). 
Unfortunately, so far Ce-FAR-1 did not diffract better than 20 Å and further crystal optimization 
is ongoing.  
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3.2.3. Structural model of Ce-FAR-1  
 
The homology search against Ce-FAR-1 suggested that the amino acid sequence of Ce-FAR-1 
show 27% identity (red mark) and 51% similarity (blue mark) with Ce-FAR-7 (Group C) as 
shown in Fig. 9A. The alignment score was high as 36.6 bits and E value was low as 2e-07 (date 
not shown). E value indicate that the number of hits see when searching a database of a particular 
size and alignment score is the sum of the scores specific for each of the aligned pairs of letters 
and as the value alignment score is high when the similarity will be high. The predications of 
domain indicate that there was single domain present in Ce-FAR-1 protein.  Secondary structure 
prediction programme shows that Ce-FAR-1 has the same helix-rich structure as Ce-FAR-7. 
Multiple sequence alignment indicates that Ce-FAR-1 has nine alpha helixes containing 116 
residues and 50 residues are coiled as shown in Fig. 9A. 
 
 
 
 
 
 
 
 
 
 
Figure 9: (A) Multiple sequence alignment between representative of the FAR protein from C. elegans 
group A and C (Ce-FAR-1 and Ce-FAR-7).  Red marks refer to those amino acids that show sequence 
identity and blue mark refer to amino acids that show sequence similarity. Alpha helices represent the 
secondary structure of Ce-FAR-1 and its comparison with Ce-FAR-7 shown in red colour.  
 
The high helical contents of the FAR family was confirmed by the first crystal structure of Ce-
FAR-7 (PDB: 2w9y), showing nine helices and no beta structures in the protein (Jordanova et al., 
2009). The single polypeptide chain of Ce-FAR-1 crystal structure contains nine helixes. The 
structure is cantered on two long amphipathic helices, α5 and α6 which do not direct contact with 
each other but are inclined to each other by about 20 degrees. Due to low number of identity 
(27%), α9 helix and some residues of α1 helix was missing in the 3D model of Ce-FAR-1 (Fig. 
9B, Ia, Ib). Ramachandran plot of Ce-FAR-1 fulfilled the test from 89.6% in most favoured 
region, 8.1% additional allowed region, 0.7% generously allowed region. There were two (1.5%) 
amino acids residues (Ala 16 & Glu9) present in the disallowed region of Ramachandran plot 
(Fig. 9B, III). So the results deduced that 3D structure of Ce-FAR-1 was not favored for good 
satisfactory model.           
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Figure 9: (B) (Ia, Ib) The alpha helices are labelled in two cartoon representation rotated relative to each 
other by 90° about the vertical axis. Blue colour shows the N-terminus region and red colour shows the C-
terminus region of the protein. (II) The van der waal Molecular surface are coloured as follow- Carbon: 
white, Oxygen: red, Nitrogen: blue, Sulphur: yellow. (III) Favoured amino acids residues in red area in 
Ramachandran plot for 3D structure of Ce-FAR-1.         
 
The structural orgination of Ce-FAR-1 (Fig. 9C, I) results in two binding pockets (P1 and P2) 
joined by cleft, which would allow to accommodate a veriety of ligands with different lengths of 
aliphatic chain. It was previously proved by determining the structure of Ce-FAR-7 (Jordanova 
et al., 2009). The cleft is capped by the helix α1 and the loop (L1 and L2) which joins them. The 
binding pocket P1 is formed 12 residues, that includes Pro3, Val4, Pro5, Pro8, Ile104, Gly111, 
Pro114, which are hydrophobic and Gln107, Tyr108, Glu112, Lys113, Ser115, which are 
hydrophilic in nature. The P1 binding pocket resisdues are covered by helices α1 and α6 and the 
loop (L1 &L7) (fig. 9C, IIa). The binding pocket P2 is formed 15 residues more than the 
resisdues of binding pocket P1, that includes Leu21, Phe93, Ala123, Ile127, Leu148, Gly150, 
which are hydrophobic and Glu17, Tyr18, Ser20, Glu100, Thr122, Lys124, His126, Tyr130, 
Thr149, which are hydrophilic in nature. The P2 binding pocket resisdues are covered by helices 
α1, α6 and α7 and the loop (L2 &L9)  (fig. 9C, IIb).  
Figure 9: (C) (I) the van der waal Molecular surface illustrate the binding pockets (P1 and P2) of Ce-FAR-
1. (IIa) 3D structure of Ce-FAR-1 shows the active site/pocket P1 include Pro3, Val4, Pro5, Pro8, Ile104, 
Gln107, Tyr108, Gly111, Glu112, Lys113, Pro114, and Ser115. (IIb) 3D structure of Ce-FAR-1 shows the 
active site/pocket P2 include Glu17, Tyr18, Ser20, Leu21, Phe93, Glu100, Thr122, Ala123, Lys124, 
His126, Ilu127, Tyr130, Leu148, Thr149 and Gly150. 
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The sequence alignment and the structural analysis would suggest that the structure of Ce-FAR-1 
is respresntative of the complete family of FAR protein. Recently the first high resolution crystal 
structure of Ce-FAR-7 from C. elegans has been reported (Jordanova et al., 2009).  Previous 
structural analysis of this family has been limited to SAXS study (Solovyova et al., 2003) and 
although the ovall molecular dimensions and the shape are consistent with our work the 
assumption, of a structural similarity of the FAR proteins with the ligand binding domain of the 
retinoic acid receptor (RXR α) and the nematode polyprotein allergens (Meenan et al., 2005) is 
incorrect.        
 
3.3. Ce-FAR-6 T50D and Ce-FAR-7 T26A mutant 
 
3.3.1. Mutation, Sequencing and Test expression 
 
To mimic phosphorylation threonine (T) at position 50 from the conserved casein kinase II site 
of Ce-FAR-6 was replaced with aspartic acid (D). The mutated primers successfully replaced the 
nucleotides ACT with GAT in the vector pETM-11 containing the Ce-FAR-6 gene. On other 
hand the CK2 site was blocked in another Ce-FAR protein, Ce-FAR-7, by replacing the 
threonine (T) at position 26 with alanine (A). The mutated primers successfully replaced the 
nucleotide ACC with GCC in the vector pETM-11 LIC containing the Ce-FAR-7 gene.  
 
 
 
 
 
 
 
 
 
 
 
Figure 10: (A) Figure shows the chemical formula of Threanine (T), Aspartic acid (D) and Alanine (A). (B) 
Alignment of wild and mutant type sequence of Ce-FAR-6 shows mutation on position number 149 
and150 that was successfully replaces nucleotide ACT with GAT. Alignment of wild and mutant type 
sequence of Ce-FAR-7 shows mutation on position number 76 that was successfully replaces nucleotide 
ACC with GCC. 
 
The mutant (non-methylated) DNA was obtained and uniform growth of the kanamycin resistant 
plasmid showed that it was successfully transformed into the E. coli XL 1 blue competent cells. 
Sequencing confirmed that one clone of Ce-FAR-6 T50D and three clones of Ce-FAR-7 T26A 
contained the desired mutation. The web based bioinformatics tool shows the mutation in Ce-
FAR-6 T50D and Ce-FAR-7 T26A mutant compared to the wild type (Sequences align, 2009) as 
shown in Fig. 10B. The molecular weight, iso-electric point and extinction coefficient of Ce-
FAR-6 (wild type), Ce-FAR-7 (wild type) and Ce-FAR6 T50D and Ce-FAR-6 T26A mutant 
have been calculated theoretically and shown in Table 4 (Expasy protparam tool, 2009).  
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Table 5: Molecular weight, extinction coefficient and iso-eletric point of Ce-FAR-6 T50D and 
Ce-FAR-7 T26A mutant and their comparison with the wild type Ce-FAR-6 and Ce-FAR-7. 
 
 
To test the expression, a positive clone of the Ce-FAR-6 T50D mutant was transformed into 
three expression strains of E. coli competent cells (BL21(DE3)pLysS, BL21(DE3)RI, 
BL21(DE3)RP) and a positive clone of the Ce-FAR-7 T26A mutant was transformed into  
expression strains of E. coli competent cells (BL21(DE3)pLysS). OD600 was measured every half 
hour until it reached 0.6-0.8 and then the cells were induced to initiate expression.  
 
After reaching the desired OD600 (cells grown at 37°C) the cells were induced with 1mM IPTG 
to initiate recombinant protein expression and then grown overnight at 20
0
C. To analyse the 
results and choose the best expression conditions, samples were taken at different time intervals 
and run on SDS-PAGE as shown in Fig. 11. The results indicate that Ce-FAR-6 T50D mutants 
were successfully expressed in Bl21(DE3)RIL, weakly expressed in Bl21(DE3)RP with no 
expression in Bl21(DE3)plysS. On the other hand, Ce-FAR-7 T26A mutants were successfully 
expressed in Bl21(DE3)plysS (Fig. 11).  
 
 
 
 
 
 
 
 
 
 
Figure 11: Expression pattern of Ce-FAR-6 T50D and FAR-7 T26A mutant (A) The gels show the 
expression of His-tagged Ce-FAR-6 T50D mutant protein in Bl21(DE3)RIL, Bl21(DE3)RP and 
Bl21(DE3)pLysS cells (B) The gel shows the expression of His-tagged Ce-FAR-6 (T50D) mutant protein 
in Bl21 (DE3) RP Competent cell. (C) The gel shows successful expression of His-tagged Ce-FAR-7 
T26A protein in Bl21(DE3)pLysS cells (red mark circle). Uninduced cell: UnI, Induced cell: 1hr, 2hr, 24hr, 
Cell lyses: CL.  
 
 
 
 
Assigned Name  Molecular  weight 
Iso-electric 
point 
0.1%Extinction 
coefficient 
Ce-FAR-6 (wild type) 22031Da 6.71 0.541 
Ce-FAR-6 T50D mutant 22045Da 6.45 0.541 
             Ce-FAR-7 18502Da 6.24 0.255 
Ce-FAR-7 T26A mutant 18471Da 6.24 0.255 
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3.3.2. Expression and Purification  
 
Bl21(DE3)RIL competent cells were used for large scale expression of Ce-FAR-6 T50D and 
Bl21(DE3)pLysS for Ce-FAR-7 T26A. Cell growth before induction is shown on Fig. 12. The 
recombinat proteins were successfully expressed and the yields were 24mg and 18mg 
respectively, per litre Culture.  
 
 
 
 
 
 
 
Figure 12: The graphs represent expression cells growth before induction, where OD600 is plotted against 
time (h). A. Ce-FAR-6 T50D; B. Ce-FAR-7 T26A. 
 
Ce-FAR-6 T50D and Ce-FAR-7 T26A mutant were purified by Ni affinity chromatography, 
using the batch method as described in Materials and Methods section. Mutant proteins were 
eluted with high imidazole and concentrated by ultra filtration to 10mg/ml, 4mg/ml and 8mg/ml.  
The purity of the eluted protein fraction was analysis by SDS-PAGE as shown in Fig 13.  
 
 
 
 
 
 
 
 
Figure 13: (A) SDS-PAGE showing the profile of affinity chromatography purification of Ce-FAR-6 T50D 
mutant protein. The size of the product was 22KDa compared with marker (M) and FT is the Flow through 
from the affinity column. (B) SDS-PAGE gel showing the profile of affinity chromatography of Ce-FAR-7 
T26A mutant protein. The size of the product was 18KDa compared with marker (M) and FT is the Flow 
through from the affinity column. 
 
3.3.3. Lipid removal, Dialysis and Phosphorylation   
 
All FAR proteins have a conserved casein kinase II phosphorylation site as shown in Fig. 2. 
Jordanova et al (2009) showed that in vitro phosphorylation with casein kinase II results in a 
81Da difference between phosphorylated and non-phosphorylated sample, confirming that Ce-
FAR-7 wild type could be phosphorylated. The phosphorylated product was not stable and a 
mutant, mimicking phosphorylation was designed – Ce-FAR-7 T26D and used in comparative 
ligand binding experiments. The result showed that Ce-FAR-7 T26D bound retinol with higher 
affinity then Ce-FAR-7 wild type (Jordanova et al, 2009). The affinity for fatty acids however 
was not significantly different to the wild type. So it was proposed that the retinol binding 
site/pocket is most likely regulated by casein kinase II in vivo as the pocket is very close to 
phosphorylation site (Jordanova et al., 2009). Two CKII genes exist in C. elegans corresponding 
to the two subunits of CKII (www.wormbase.org).  
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Based on the described above experiments (Jordanova et al, 2009) we initiated the study on Ce-
FAR-6 CK II site by designing, cloning and purifying Ce-FAR-6 T50D mutant (as described 
elsewhere). The final goal is this mutant to be used in comparative lipid binding experiments as 
already shown for Ce-FAR-7 (Jordanova et al, 2009). To remove bound lipids the purified 
protein was incubated with hydrophobic matrix Lipidex-1000, followed by dialysis. The protein 
was stable and it was stored at -70°C for future experiments. 
 
As described above, phosphorylation of Ce-FAR-7 in vitro with casein kinase II showed that Ce-
FAR-7 has been phosphorylated (Jordanova et al., 2009). In order to prove that the protein is 
phosphorylated, a mutant (T26A) with blocked phosphorylation site was designed, expressed and 
purified (as described elsewhere). After dialysis the protein was in vitro phosphorylated and 
prepared for mass spectral analysis.  
 
 
4 Conclusions 
 
The nematode FAR proteins may have an important effect on the efficacy of some classes of 
antihelminthic drugs. The 19 kDa retinol-binding protein of O. volvulus (presumably Ov-FAR-1), 
for example, has been demonstrated to bind ivermectin (Lal, 1996) which is the principle drug 
used to control onchocerciasis in West Africa. The protein could therefore play a role in the 
delivery of the drug to, or within the parasite, or alternatively it could diminish its effect or 
possibly even be involved in the evolution of drug resistance. It is even conceivable that, with 
their highly novel structures, the FAR proteins themselves may constitute a target for the design 
of new antihelminthic drugs. 
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7 Appendixes 
 
Appendix I  
 
Sequence of Ce-FAR-1 (549 Nucleotide)  
ATGATCCGTGCCACTATCATCCTCGCCGCTGTCGCTGCCCTCGCCTTCTCTGCTCCAGTCCCGGAGGTCCCAGAGAA
CTATGACGATATCCCAGCTGAATACAAGTCCCTTATCCCAGCCGAGGTCTCCGAGCATCTTAAGTCCATCACCCCAG
AAGAGAAGGCTATTCTTAAGGAGGTCGCCAAGGGATACAAGGACTTCAAGAGCGAGGATGATTTCTTGAACGCCCTC
AAGGAAAAGTCTCCAACTCTCCACGAGAAGGCCTCCAAGCTCCACCAAATCGTCAAGGACAAGGTCAACGCTCTCAA
TGATGAGGCTAAGGCTTTCGTCAAGAAGGCTATCGCTGAAGGACGTAAGATCCACGCTCAATACTTGGCCGGAGAGA
AGCCATCCCTCGACACCCTCAAGACCACCGCCAAGACCCACATCGAAGCCTACAAGGGACTTTCCCAAGATGCCAAG
GACTCCATCGCCAAGGAATTCCCAATCCTCACCGGATTCTTCAAGAACGAGAAGGTTCAAGCCATGGTCGGACAATA
CCTCAACTAA 
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Amino acid sequence of Ce-FAR-1 (182 AA) 
MIRATIILAAVAALAFSAPVPEVPENYDDIPAEYKSLIPAEVSEHLKSITPEEKAILKEVAKGYKDFKSEDDFLNAL
KEKSPTLHEKASKLHQIVKDKVNALNDEAKAFVKKAIAEGRKIHAQYLAGEKPSLDTLKTTAKTHIEAYKGLSQDAK
DSIAKEFPILTGFFKNEKVQAMVGQYLN* 
 
Sequence of Ce-FAR-2 (549 Nucleotide)  
ATGATCCGCGCCTTCCTCGTCGTAGCCCTTGCCTCCGTGGCTGTCTTCTCTGCCCCAATCCCAGAGGTTCCACAGAA
CTTCGACGACATCCCAGCCGAGTACAAGGGACTCATCCCAGCTGAAGTTGCCGAGCACCTCAAGGCCATCACCGCTG
AGGAGAAGGCTGCTCTTAAGGAACTCGCCCAAAACCACAAGGAATACAAGACCGAGGAAGAATTCAAGGCTGCTCTC
AAGGAAAAGTCTCCATCCCTTTACGAGAAGGCTGGAAAGCTCGAGGCTCTCCTCACCGCTAAATTCGAGAAACTCGA
TGCCACCGCTCAGGCTCTTGTCAAGAAGATCATCGCCAAGGGACGTGAACTCCACCAACAATACCTCGCCGGAGATA
AGCCAACTCTTGATTCTCTTAAGGAACTCGCCAAGGGATACATCGCTGAATACAAGGCTCTTTCTGATGACGCCAAG
GCTACCATCACCGCTGAGTTCCCAATCCTCACTGGATTCTTCCAAAACGAAAAGATTCAAGCCATCGTCGGACAATA
CGTCAACTAA 
 
Amino acid sequence of Ce-FAR-2 (182 AA) 
MIRAFLVVALASVAVFSAPIPEVPQNFDDIPAEYKGLIPAEVAEHLKAITAEEKAALKELAQNHKEYKTEEEFKAAL
KEKSPSLYEKAGKLEALLTAKFEKLDATAQALVKKIIAKGRELHQQYLAGDKPTLDSLKELAKGYIAEYKALSDDAK
ATITAEFPILTGFFQNEKIQAIVGQYVN* 
 
Sequence of Ce-FAR-3 (570 Nucleotide)  
ATGTCTCGTCTTTTCGCTTTCAACGTTTTCTGCTTGGTTCTTCTCCGTTTCTCAGCTGCTGCTCCAGCTGATGATTC
TTCTCCATTCTCTCAAATTTTGAAGCAACACAAAGATCTCCTTCCATCCGAAGTTGTTCAAGCCTATCAGGATTTGT
CTCCAGAAGAGAAGGCTGCATTGAAGGATGTATTCAAGAACTACAAGAGCTACAAAAACGAAGGAGAATTGATTGCT
GCTCTCAAAGAAAAGTCTTCAAGCTTGGGAGAAAAGGCTGAGAAGCTTCAAGCTAAGCTCCAAAAGAAGGTTGATGC
ATTGAGCCCAAAACCAAAGGATTTTGTTAACGAGCTCATTGCTGGAGGACGTGGTCTTTATGCTCGTTCTGTTAATG
GAGAGAAGATCTCAGTTTCCGAGATCAAGCTTCTCATTGAAACCCAAGTTGCTGCATACAAGGCATTGCCAGCTGAG
GCTCAAGACGAGTTGAAGAAAAATTTCGGAGGAGTCGCCAAGTTTTTGGAGGATGACAAGACTCAAACACTCATTGC
CAAGCTTCTTGAGAAGAACAATAACCAGTAA 
 
Amino acid sequence of Ce-FAR-3 (189 AA) 
MSRLFAFNVFCLVLLRFSAAAPADDSSPFSQILKQHKDLLPSEVVQAYQDLSPEEKAALKDVFKNYKSYKNEGELIA
ALKEKSSSLGEKAEKLQAKLQKKVDALSPKPKDFVNELIAGGRGLYARSVNGEKISVSEIKLLIETQVAAYKALPAE
AQDELKKNFGGVAKFLEDDKTQTLIAKLLEKNNNQ* 
 
Sequence of Ce-FAR-4 (618 Nucleotide)  
ATGAGTAAATTACTTCTACTTGTACTTTCTCTTCTCTTTTTTATTACATCAGCTTTTCCATTCGGAGAACCACAAGC
GGGAGGATTTCAAAAATTTAAGAACTTACTTCCAAGGGAGCTTGTGGAGGCCTACAGTAACCTGAGTCAAAAAGATC
AACCTGATCTGAAAGATGTATTCCGTAATCATCAAAACTACCGAAATGAACAAGAAATGGTTAATGCTTTGAAAATG
AAAAATCCAGCACTCGGAGCCCGAATGGAACGGAGATTGATGGCTTTGAAGCAGAAAATCGATGGATTGAGTAGCGA
AGAAGCGAAAGGATTTATTCAGAATTTGATTTCAACTGGAAGACAAATTTATGCTCAACGGCTTAATGGACAACAAA
TGGATCAGTCACAATTGAGACAAGTTGGAATGGGAATTGCAATGCACTATCGATCATTACCTCCATATGCACAACAG
GAACTTCAAAGTACTTTTCCACAAATCTTCCAATTCATGAGACAAATGCGTGAACAACGTCTTCGAAGCATGATGGG
CGGATTCTTTGGCGGCGGAGGTGGAATCGGAATGGGACAAGGCATGGGACAAGGCATGGGAATGGGTATGGGAAAAT
AA 
 
Amino acid sequence of Ce-FAR-4 (205 AA) 
MSKLLLLVLSLLFFITSAFPFGEPQAGGFQKFKNLLPRELVEAYSNLSQKDQPDLKDVFRNHQNYRNEQEMVNALKM
KNPALGARMERRLMALKQKIDGLSSEEAKGFIQNLISTGRQIYAQRLNGQQMDQSQLRQVGMGIAMHYRSLPPYAQQ
ELQSTFPQIFQFMRQMREQRLRSMMGGFFGGGGGIGMGQGMGQGMGMGMGK* 
 
Sequence of Ce-FAR-5 (531 Nucleotide)  
ATGTTACTCCGTTTCTTTGCTATTTTATTAATTTTTCATTTCTCATTTGCTGCTGATGGAATATTTGAAGCTGTTAT
TGAGAGCTATAAAGATGCTCTTCCACCAAAAGTTGTTGCGGCTTTTGATAATTTGAGTCCAGGGGAAAGTGCTATTA
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TGAAAGAAGTATTCATGAATTATGATAAATTTACAAGTATTGCTGATCTGATTGTTGCAATCAAGAAGAAATCGGAA
TCACTTGGATCGTTTTTCGAGAAACTTTACATTGAAATTGACGCTGAAATTCAGGCATTAACACCGGAAACAAAGAA
ATTTGTAACTGAAATGTTAGGAATTGGCAGAGCAATTTATACTGCACAAATTGTTGGAATTCCATTAGATTCTAAAG
AAGTCCTACCTGTATTTGCAAAACAATTTACTTCGTTCAAATCACTATCGGATGCTACAAAGGAAGAACTTGAAAAA
ACATTCCTCGGTCTCTACAAATTCGCTTCAAACGACAAGATCAAGACTGAGATTGATAAATTGTTGTGA 
 
Amino acid sequence of Ce-FAR-5 (176 AA) 
MLLRFFAILLIFHFSFAADGIFEAVIESYKDALPPKVVAAFDNLSPGESAIMKEVFMNYDKFTSIADLIVAIKKKSE
SLGSFFEKLYIEIDAEIQALTPETKKFVTEMLGIGRAIYTAQIVGIPLDSKEVLPVFAKQFTSFKSLSDATKEELEK
TFLGLYKFASNDKIKTEIDKLL* 
 
Sequence of Ce-FAR-6 (555 Nucleotide)  
ATGATCCGCATCTTCCTTGTCATAGCACTTGCCTCCGTCGCTGTCTTTTCTGCTCCAATTTCACGCTTACCACAAAG
CTTAGACGACATCCCAGCTGAGTTCAAGGAACTCATCCCAGCTAAAGTTACTGAATACCTTAAATCCATCACTACTG
AGGAGAAAGCTGCTATTAAGGAATTTATCAAAAGTGTTATGGGAGGAAACAAATCTGTTGAAGAATTGAGTGCTGAT
ATCAAGGAGCGGTCCCCATCCCTGTACGCTAAGGTTGAAAAACTCGACGTCCTACTCCGCACAAAACTCGCGAAACT
CGACCCCGCCGCTCTGGCTTTATTCGGGAAAGTCATCGCTCAGGGACTTTCTTTCCGGCAACAGTTCCATGCCGGAT
ACCAGCCAACTCCTGAGATGGTAAAGAAACTCTTCAAGGGATACATTGCTGAATATAAAACACTTTCTGAAAACGCC
AAGGCCACCATCACCGATGAGTTCCCCATCGTCGTTGAATTCTTTCAACACGAGAAAATTCAAGCCATCATCCAACA
GATCGTGAACTACTAA 
 
Amino acid sequence of Ce-FAR-6 (184 AA) 
MIRIFLVIALASVAVFSAPISRLPQSLDDIPAEFKELIPAKVTEYLKSITTEEKAAIKEFIKSVMGGNKSVEELSAD
IKERSPSLYAKVEKLDVLLRTKLAKLDPAALALFGKVIAQGLSFRQQFHAGYQPTPEMVKKLFKGYIAEYKTLSENA
KATITDEFPIVVEFFQHEKIQAIIQQIVNY* 
 
Sequence of Ce-FAR-7 (417 Nucleotide)  
ATGAGCGTTGCTTCACTTCCAGAATGTGTCAAAAACTTTTTCCCAACTGAACAACTCGAGTTCTCCTCATCAATTAC
CGCTGACGAGAAGCCAGTTCTTCATGAGGTATTCCAAAAGCATTCATGTTTCTCACAATGTGGTGAAATGATTGACG
AGGTCTCGAAAAAGCATCCAGAATTGGGAAAACGGTTGGCAACTGTGTTGGAGGGGAACAAGAAACGTTTGGATGGT
TTGAGCCCGGCTGCTGTTGAGTATGCCAAGAAGCTCATACACATGGTAACCACCACCTTGTGCTCCTTAACCGTCGG
AAAACCAATTGATGATGCAGATGCAAAACGTCTTCACCAGGAATTCCAAAGCCTATCTTCAGAAGATCAGGCTGCGC
TGAGAAAGAATAATCCGGATATTAAATTTTGA 
 
Amino acid sequence of Ce-FAR-7 (138 AA) 
MSVASLPECVKNFFPTEQLEFSSSITADEKPVLHEVFQKHSCFSQCGEMIDEVSKKHPELGKRLATVLEGNKKRLDG
LSPAAVEYAKKLIHMVTTTLCSLTVGKPIDDADAKRLHQEFQSLSSEDQAALRKNNPDIKF* 
 
Sequence of Ce-FAR-8 (699 Nucleotide)  
ATGTTTACCTTACGGGCATGCTCCTTAATTCTTGTGTCAGTGGCTGTGTTCGTTTTGGGTCGCCCCGCTGAAGAACA
AATGACCGAGAAGGATTTTACAAACTTGGTGTTCACTGTGGAGAAGTTTGATCAAATTTTGAAGGCCTATTCTGAAT
ACAAACAATTCATGCCTTCTTACGTTCTGGAACCACTTGATAACATCACCGACGAACAGAAAACTCAGGCAGTTCAG
ATGGTGAATGACTATCACGCAGGCAAGTTTGAGCCGAAGAACTACGATGAGTACATCGCAATCATGAAGAAGAGCTA
TCCAGCATTGGCAGGTCCATATGAGACAATGTACAACAAGTACAAAGAACAGGTTGCCAAATTGGGACCAAAGGGAC
AAGAATATTGCAATGGGCTCGAAGCTCAAATGTACACCGATGCCTCCCCTGACCGTGTTGTCTGGGCTTGCCATATC
TTCAACAATGCCAAGTCCGCAGTTAGTGGAGCAAAAGCTCTTCTTCAGGATGATTCGGAAGCGGCAAAGATTGAAGA
AGCATTCCCAGAGGCTGTGAAACTTCTTAATAGCAAAAAATTTGAAGCCTACTCGATTATCGTTAACAACCTGAAAC
CATTGGATTGCGTCAAGGATCGTGAGCAAGTCTTCAATACTATCAAATTGATGGATAAGCAAAGTGTGCTCACCAAT
AATTGA 
 
Amino acid sequence of Ce-FAR-8 (232 AA) 
MFTLRACSLILVSVAVFVLGRPAEEQMTEKDFTNLVFTVEKFDQILKAYSEYKQFMPSYVLEPLDNITDEQKTQAVQ
MVNDYHAGKFEPKNYDEYIAIMKKSYPALAGPYETMYNKYKEQVAKLGPKGQEYCNGLEAQMYTDASPDRVVWACHI
FNNAKSAVSGAKALLQDDSEAAKIEEAFPEAVKLLNSKKFEAYSIIVNNLKPLDCVKDREQVFNTIKLMDKQSVLTN
N* 
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